Your browser doesn't support javascript.
loading
Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells.
Riegel, Dania; Romero-Fernández, Elena; Simon, Malte; Adenugba, Akinbami Raphael; Singer, Katrin; Mayr, Roman; Weber, Florian; Kleemann, Mark; Imbusch, Charles D; Kreutz, Marina; Brors, Benedikt; Ugele, Ines; Werner, Jens M; Siska, Peter J; Schmidl, Christian.
Afiliação
  • Riegel D; Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.
  • Romero-Fernández E; Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.
  • Simon M; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Adenugba AR; Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Singer K; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany; Department of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Mayr R; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, 93053 Regensburg, Germany.
  • Weber F; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany.
  • Kleemann M; Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany.
  • Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Kreutz M; Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Ugele I; Department of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Werner JM; Department of Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Siska PJ; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Schmidl C; Leibniz Institute for Immunotherapy (LIT), 93053 Regensburg, Germany. Electronic address: christian.schmidl@ukr.de.
Mol Cell ; 83(4): 622-636.e10, 2023 02 16.
Article em En | MEDLINE | ID: mdl-36657444
Despite extensive studies on the chromatin landscape of exhausted T cells, the transcriptional wiring underlying the heterogeneous functional and dysfunctional states of human tumor-infiltrating lymphocytes (TILs) is incompletely understood. Here, we identify gene-regulatory landscapes in a wide breadth of functional and dysfunctional CD8+ TIL states covering four cancer entities using single-cell chromatin profiling. We map enhancer-promoter interactions in human TILs by integrating single-cell chromatin accessibility with single-cell RNA-seq data from tumor-entity-matching samples and prioritize cell-state-specific genes by super-enhancer analysis. Besides revealing entity-specific chromatin remodeling in exhausted TILs, our analyses identify a common chromatin trajectory to TIL dysfunction and determine key enhancers, transcriptional regulators, and deregulated genes involved in this process. Finally, we validate enhancer regulation at immunotherapeutically relevant loci by targeting non-coding regulatory elements with potent CRISPR activators and repressors. In summary, our study provides a framework for understanding and manipulating cell-state-specific gene-regulatory cues from human tumor-infiltrating lymphocytes.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Humans Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Limite: Humans Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha